TuHURA BIOSCIENCES, INC./NV Investment Income, Interest
TuHURA BIOSCIENCES, INC./NV (HURA) reported Investment Income, Interest of $13.40 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2019-06-03
- TuHURA BIOSCIENCES, INC./NV investment income, interest for the quarter ending 2019-03-31 was $13.40K, a 129.01% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV investment income, interest for the quarter ending 2018-12-31 was $16.27K, a 6824.26% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV investment income, interest for the quarter ending 2018-09-30 was $19.84K, a 12620.51% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV investment income, interest for the quarter ending 2018-06-30 was $27.00K, a 12881.73% increase year-over-year.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2019-03-31 | $13.40K 10-Q · filed 2019-05-14 | $29.67K derived: sum of 2 quarters · filed 2019-05-14 | $49.51K 10-Q · filed 2019-05-14 | $76.52K derived: sum of 4 quarters · filed 2019-06-03 |
| 2018-12-31 | $16.27K 10-Q · filed 2019-02-11 | $36.12K 10-Q · filed 2019-02-11 | $63.12K derived: sum of 3 quarters · filed 2019-06-03 | $68.97K derived: sum of 4 quarters · filed 2019-06-03 |
| 2018-09-30 | $19.84K 10-Q · filed 2018-11-13 | $46.85K derived: sum of 2 quarters · filed 2019-06-03 | $52.70K derived: sum of 3 quarters · filed 2019-06-03 | $52.93K derived: sum of 4 quarters · filed 2019-06-03 |
| 2018-06-30 | $27.00K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $32.85K derived: sum of 2 quarters · filed 2019-06-03 | $33.09K derived: sum of 3 quarters · filed 2019-06-03 | $33.24K 8-K · filed 2019-06-03 |
| 2018-03-31 | $5.85K 10-Q · filed 2019-05-14 | $6.08K derived: sum of 2 quarters · filed 2019-05-14 | $6.24K 10-Q · filed 2019-05-14 | $6.45K derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-12-31 | $235.00 10-Q · filed 2019-02-11 | $391.00 10-Q · filed 2019-02-11 | $599.00 derived: sum of 3 quarters · filed 2019-06-03 | $747.00 derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-09-30 | $156.00 10-Q · filed 2018-11-13 | $364.00 derived: sum of 2 quarters · filed 2019-06-03 | $512.00 derived: sum of 3 quarters · filed 2019-06-03 | $572.00 derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-06-30 | $208.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $356.00 derived: sum of 2 quarters · filed 2019-06-03 | $416.00 derived: sum of 3 quarters · filed 2019-06-03 | $457.00 8-K · filed 2019-06-03 |
| 2017-03-31 | $148.00 10-Q · filed 2018-05-15 | $208.00 derived: sum of 2 quarters · filed 2018-05-15 | $249.00 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $60.00 10-Q · filed 2018-02-14 | $101.00 10-Q · filed 2018-02-14 | ||
| 2016-09-30 | $41.00 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |